Progression to insulin-requiring diabetes in seronegative prediabetic subjects: The role of two HLA-DQ high-risk haplotypes

Diabetologia

Volumn 45, Issue 1, 2002, Pages 66-76

  Pietropaolo, M ^a   Becker, D J ^a   LaPorte, R E ^b   Dorman, J S ^b   Riboni, S ^a   Rudert, W A ^a   Mazumdar, S ^b   Trucco, M ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

2 HLA DQ high risk haplotypes; Autoantibodies; Islet cell autoimmunity; Seronegative insulin requiring diabetes

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; HUMORAL IMMUNITY; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AUTOANTIBODIES; CHILD; DEMOGRAPHY; DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; ISOENZYMES; MIDDLE AGED; PENNSYLVANIA; PREDIABETIC STATE; PREVALENCE; REGISTRIES; RISK ASSESSMENT; TIME FACTORS;

EID: 0036165756     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s125-002-8246-5     Document Type: Article

References (63)

1. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives
2. Prediction of type I diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512bdc/IA-2 autoantibodies
3. Missense mutation Gly574Ser in the transcription factor HNF-1 alpha is a marker of atypical diabetes in African-American children
4. B-cell autoimmunity in white and black children and adolescent with insulin-dependent diabetes mellitus
5. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
6. Are GAD65 and IA-2 autoantibodies sufficient to predict type 1 diabetes?
7. Absence of islet autoantibodies at diabetes onset does not rule out type 1A diabetes
8. Persistent T cell anergy in human type 1 diabetes
9. Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients
10. To be or not to be ASP 57, that is the question
11. Worldwide differences in the incidence of type 1 diabetes are associated with amino acid variation at position 57 of the HLA-DQβ chain
12. A combination of HLA-DQ beta Asp 57-negative and HLA-DQ Arg 52 confers susceptibility to insulin-dependent diabetes mellitus
13. Susceptibility to type I diabetes in Spanish patients correlates quantitatively with expression of HLA-DQα Arg 52 and HLA-DQβ non-Asp 57 alleles
14. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families
15. Molecular basis for HLA-DQ association in IDDM
16. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus
17. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes
18. HLA antigens and diabetes mellitus
19. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
20. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: A family study
21. Immunogenetics of HLA-associated diseases
22. Genetics of type 1 diabetes mellitus
23. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes
24. HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: A HuGE review
25. Epidemiology, clinical aspects, and biology of IDDM patients under age of 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment
26. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a Caucasian population: Are these type 1 b diabetes cases?
27. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes
28. The Pittsburgh insulin-dependent diabetes mellitus registry: The relationship of insulin-dependent diabetes mellitus incidence to social class
29. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
30. Sequence-specific priming and exonuclease-released fluorescence detection of HLA-DQB1 alleles
31. Strategies for synthesis of double-labelled fluorescent oligonucleotide probes for 5′ nuclease assay
32. Advancements in DNA technology as applied to the study of human histocompatibility complex
33. A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
34. Autoantibodies to protein tyrosine phosphatase-like proteins in type 1 diabetes: Overlapping specificities to phogrin and ICA512/IA-2
35. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus
36. A novel micro-assay for insulin autoantibodies
37. Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in families
38. The Diabetes Prevention Trial-type 1 diabetes (DPT-1): Implementation of screening and staging of relatives
39. Expression of "cytoplasmic" islet cell antigens by rat pancreas
40. Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics
41. Beta-cell autoantibodies in infants and toddlers without IDDM relatives: Diabetes autoimmunity study in the young (DAISY)
42. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
43. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
44. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes mellitus
45. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
46. Therapeutic controversy. Prevention and treatment of diabetes in children
47. Stability of autoantibodies and their relation to genetic and metabolic markers of type I diabetes in initially unaffected school-children
48. Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function
49. Children with obesity and diabetes; Is it type 1 or type 2?
50. A novel subtype of type 1 diabetes mellitus characterized by rapid onset and absence if diabetes-related antibodies
51. Rapid onset of type 1 diabetes with pancreatic exocrine dysfunction
52. Maturity-onset diabetes of youth in Black Americans
53. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes
54. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes
55. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials
56. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes
57. T-cell responses to autoantigens in IDDM. The search for the Holy Grail
58. Restricted TCR Vβ gene expression and enterovirus infection in type I diabetes: A pilot study
59. Autoimmunity and genetic factors contribute to the risk of insulin-dependent diabetes mellitus in families: Islet cell antibodies and HLA DQ heterodimers
60. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children
61. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: Report of phase II of the Second International Immunology of Diabetes Society Workshop for standardization of T-cell assays in type 1 diabetes
62. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4
63. T-cell markers in type I diabetes: Progress, prospects and realistic expectations